Table 6.
Prescribers’ reports of adverse health outcomes in clients who received additional unsupervised doses.
| Methadone prescribers | Buprenorphine prescribers | SROM prescribers | |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Number individuals prescribing OAT | 86 | 83 | 42 |
| Non-fatal overdoses (with or without emergency department visit) | 21 (24%) | 23 (28%) | 8 (19%) |
| Emergency department visits because of substance use | 22 (26%) | 27 (33%) | 6 (14%) |
| Hospital admissions because of substance use | 23 (27%) | 18 (22%) | 6 (14%) |
| Deaths due to overdose | 10 (12%) | 14 (17%) | 5 (12%) |
Note: SROM = slow release oral morphine; Prescribers were asked to indicate whether they were aware of the incidents listed in the table occurring among their patients with additional unsupervised doses during the pandemic. The values in the table reflect the number (and percentage) of prescribers for each OAT type who reported being aware of the relevant event.